Tox species, study length, skipped studies and first dose for all 109 approved bispecifics, ADCs, oligonucleotides, gene and cell therapies
This product has been approved and will launch on the scheduled date.
Launch date
Monday
November 9, 2026
Countdown
20 days
Reactions
How voting works
Anonymous vote · one per IP